Bringing the Benefits of High-Dose Haemodialysis to the Home with a Novel Haemodialysis System

Chairperson:

Pieter ter Wee¹

Speakers:

Chris McIntyre,² Tom Cornelis,³ Bruce Culleton⁴

1. VU University Medical Center, Amsterdam, the Netherlands
2. School of Medicine, University of Nottingham, Nottingham, UK
3. Maastricht University Medical Centre, Maastricht, the Netherlands
4. Renal Therapeutic Area, Baxter Healthcare, Chicago, Illinois, USA

Disclosure:

Pieter ter Wee and Chris McIntyre have received research funding, speaking honoraria, and consulting fees from Baxter. Tom Cornelis has received research funding and speaking honoraria from Baxter. Bruce Culleton is an employee of Baxter Healthcare.

Acknowledgements:

Writing assistance provided by Dr Saroshi Amirthalingam.

Support:

The publication of this article was funded by Baxter Healthcare. The views and opinions ex- pressed are those of the authors and not necessarily of Baxter Healthcare.

Citation:

EMJ Nephrol. 2014;1[1]:37-44. DOI/10.33590/emjnephrol/10310212. https://doi.org/10.33590/emjnephrol/10310212.

Each article is made available under the terms of the Creative Commons Attribution-Non Commercial 4.0 License.